These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18506152)

  • 1. Do we need more nomograms for predicting outcomes in patients with prostate cancer?
    Kattan MW
    Nat Clin Pract Urol; 2008 Jul; 5(7):366-7. PubMed ID: 18506152
    [No Abstract]   [Full Text] [Related]  

  • 2. Nomograms for prostate cancer.
    Stephenson AJ; Kattan MW
    BJU Int; 2006 Jul; 98(1):39-46. PubMed ID: 16831140
    [No Abstract]   [Full Text] [Related]  

  • 3. More nomograms or better evidence of efficacy: what do we need in urologic oncology?
    Catto JW
    Eur Urol; 2008 Jul; 54(1):11-2. PubMed ID: 18262334
    [No Abstract]   [Full Text] [Related]  

  • 4. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
    Nguyen CT; Zelefsky MJ; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
    Shariat SF; Karakiewicz PI; Suardi N; Kattan MW
    Clin Cancer Res; 2008 Jul; 14(14):4400-7. PubMed ID: 18628454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
    Chun FK; Karakiewicz PI; Briganti A; Walz J; Kattan MW; Huland H; Graefen M
    BJU Int; 2007 Apr; 99(4):794-800. PubMed ID: 17378842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive models in diagnosing indolent cancer.
    Bangma CH; Roobol MJ; Steyerberg EW
    Cancer; 2009 Jul; 115(13 Suppl):3100-6. PubMed ID: 19544551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting outcomes in prostate cancer: how many more nomograms do we need?
    Ross RW; Kantoff PW
    J Clin Oncol; 2007 Aug; 25(24):3563-4. PubMed ID: 17704399
    [No Abstract]   [Full Text] [Related]  

  • 9. Nomograms are more meaningful than severity-adjusted institutional comparisons for reporting outcomes.
    Hixson ED; Kattan MW
    Eur Urol; 2006 Apr; 49(4):600-3. PubMed ID: 16439054
    [No Abstract]   [Full Text] [Related]  

  • 10. An updated catalog of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
    Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inventory of prostate cancer predictive tools.
    Shariat SF; Karakiewicz PI; Margulis V; Kattan MW
    Curr Opin Urol; 2008 May; 18(3):279-96. PubMed ID: 18382238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
    Nguyen CT; Kattan MW
    Cancer; 2009 Jul; 115(13 Suppl):3039-45. PubMed ID: 19544545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial comment on: development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
    Kattan MW
    Eur Urol; 2008 Sep; 54(3):611. PubMed ID: 18207318
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictive modeling in prostate cancer. Conclusions and reflections.
    Denis LJ; Gospodarowicz MK
    Cancer; 2009 Jul; 115(13 Suppl):3160-2. PubMed ID: 19544535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebuttal from authors re: James W.F. Catto. More nomograms or better evidence of efficacy: what do we need in urologic oncology? Eur Urol 2008;54:11-12.
    Shariat SF; Margulis V; Karakiewicz PI
    Eur Urol; 2008 Jul; 54(1):13-5. PubMed ID: 18329787
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels.
    Ide H; Yasuda M; Nishio K; Saito K; Isotani S; Kamiyama Y; Muto S; Horie S
    Anticancer Res; 2008; 28(4C):2487-92. PubMed ID: 18751439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nomogram as predictive model in clinical practice].
    Ohori Tatsuo Gondo And Riu Hamada M; Gondo T; Hamada R
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):901-6. PubMed ID: 19542708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open to debate. The motion: Nomograms should become a routine tool in determining prostate cancer prognosis.
    Briganti A; Karakiewicz PI; Joniau S; Van Poppel H
    Eur Urol; 2009 Mar; 55(3):743-7. PubMed ID: 19081177
    [No Abstract]   [Full Text] [Related]  

  • 20. The search for better prognostic factors for men treated for localized prostate cancer continues.
    Karakiewicz PI; Suardi N; Shariat SF
    Eur Urol; 2008 Apr; 53(4):689-90. PubMed ID: 18093722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.